• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?

作者信息

Avila-Aguero Maria L, Ulloa-Gutierrez Rolando, Falleiros-Arlant Luiza H, Porras Oscar

机构信息

a Servicio de Infectología e Inmunología/Reumatología , Hospital Nacional de Niños 'Dr. Carlos Sáenz Herrera' , San José , Costa Rica.

b Medical School of the Santos Metropolitan University , Sao Paulo , Brazil.

出版信息

Expert Rev Vaccines. 2017 Jul;16(7):1-4. doi: 10.1080/14760584.2017.1334555. Epub 2017 Jun 16.

DOI:10.1080/14760584.2017.1334555
PMID:28535704
Abstract
摘要

相似文献

1
Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?拉丁美洲的肺炎球菌结合疫苗：在预防19A血清型方面，10价肺炎球菌结合疫苗（PCV10）和13价肺炎球菌结合疫苗（PCV13）相似吗？
Expert Rev Vaccines. 2017 Jul;16(7):1-4. doi: 10.1080/14760584.2017.1334555. Epub 2017 Jun 16.
2
Streptococcus pneumoniae serotype 19A: worldwide epidemiology.19A 型肺炎链球菌：全球流行病学。
Expert Rev Vaccines. 2017 Oct;16(10):1007-1027. doi: 10.1080/14760584.2017.1362339. Epub 2017 Aug 28.
3
How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018.2016 年至 2018 年期间，在比利时将 13 价肺炎球菌结合疫苗（PCV13）切换为 10 价肺炎球菌结合疫苗（PCV10）后，鼻咽部肺炎球菌携带情况如何演变。
Euro Surveill. 2020 Feb;25(5). doi: 10.2807/1560-7917.ES.2020.25.5.1900303.
4
The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage.肺炎球菌结合疫苗对 19A 型鼻咽携带的影响。
Expert Rev Vaccines. 2019 Dec;18(12):1243-1270. doi: 10.1080/14760584.2019.1675521.
5
Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) study.十价和十三价肺炎球菌结合疫苗预防加拿大魁北克19A血清型侵袭性肺炎球菌疾病的有效性。一项加拿大免疫研究网络（CIRN）研究。
Vaccine. 2024 Dec 2;42(26):126379. doi: 10.1016/j.vaccine.2024.126379. Epub 2024 Sep 26.
6
Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations.比较 10 价肺炎球菌结合疫苗与 13 价肺炎球菌结合疫苗对等效人群中侵袭性肺炎球菌病的影响。
Clin Infect Dis. 2017 Nov 13;65(11):1780-1789. doi: 10.1093/cid/cix685.
7
Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.比较 13 价和 7 价肺炎球菌结合疫苗在降低鼻咽部定植方面的免疫原性和疗效：一项随机、双盲试验。
Clin Infect Dis. 2013 Oct;57(7):952-62. doi: 10.1093/cid/cit428. Epub 2013 Jun 26.
8
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.广泛使用十价和十三价肺炎球菌结合疫苗后剩余侵袭性肺炎球菌疾病的血清型分布（PSERENADE项目）：一项全球监测分析
Lancet Infect Dis. 2025 Apr;25(4):445-456. doi: 10.1016/S1473-3099(24)00588-7. Epub 2024 Dec 17.
9
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance.PCV10 和 PCV13 对 6C 型肺炎球菌疾病、携带和抗菌药物耐药性的影响。
Vaccine. 2024 Apr 30;42(12):2983-2993. doi: 10.1016/j.vaccine.2024.03.065. Epub 2024 Mar 28.
10
Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.越南胡志明市婴幼儿接种 10 价与 13 价肺炎球菌结合疫苗的免疫原性和反应原性：一项随机对照试验。
Lancet Infect Dis. 2019 May;19(5):497-509. doi: 10.1016/S1473-3099(18)30734-5. Epub 2019 Apr 8.

引用本文的文献

1
Effectiveness of pneumococcal conjugate 13-valent vaccine against severe pneumonia in Panama: a matched case-control study.13价肺炎球菌结合疫苗对巴拿马重症肺炎的有效性：一项配对病例对照研究。
J Pediatr (Rio J). 2025 Jul-Aug;101(4):601-607. doi: 10.1016/j.jped.2025.03.008. Epub 2025 May 10.
2
A Narrative Review of Pneumococcal Conjugate Vaccine Choices for Greater Access and Protection against Pneumococcal Diseases in the Philippines.关于菲律宾扩大肺炎球菌结合疫苗选择以增加对肺炎球菌疾病的可及性和保护的叙述性综述。
Acta Med Philipp. 2025 Mar 31;59(4):151-158. doi: 10.47895/amp.v59i4.10372. eCollection 2025.
3
Continuous Effectiveness of Pneumococcal 13-Valent Conjugate Vaccine on Pediatric Pneumococcal Otomastoiditis: Results of 15 Years of Active/Prospective Surveillance in a Mexican Hospital on the Mexico-US Border.
13价肺炎球菌结合疫苗对儿童肺炎球菌性耳乳突炎的持续有效性：墨西哥边境一家墨西哥医院15年主动/前瞻性监测结果
Cureus. 2021 Aug 31;13(8):e17608. doi: 10.7759/cureus.17608. eCollection 2021 Aug.
4
Chimeric oligosaccharide conjugate induces opsonic antibodies against serotypes 19A and 19F.嵌合寡糖缀合物诱导针对19A和19F血清型的调理素抗体。
Chem Sci. 2020 Jun 26;11(28):7401-7407. doi: 10.1039/d0sc02230f.
5
Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.在巴西婴儿中用13价肺炎球菌结合疫苗（PCV13）替代10价肺炎球菌结合疫苗（PCV10）的成本效益分析。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1162-1172. doi: 10.1080/21645515.2020.1809266. Epub 2020 Sep 23.
6
Emergence of serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10.在哥伦比亚波哥大，10 价肺炎球菌结合疫苗（PCV10）引入后，血清型 19A（Spn19A）成为儿童侵袭性肺炎球菌病的主要病因。
Hum Vaccin Immunother. 2020 Sep 1;16(9):2300-2306. doi: 10.1080/21645515.2019.1710411. Epub 2020 Feb 20.
7
Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.奥地利国家免疫计划引入 10 价肺炎球菌结合疫苗前后儿童和成人侵袭性肺炎球菌病。
PLoS One. 2019 Jan 10;14(1):e0210081. doi: 10.1371/journal.pone.0210081. eCollection 2019.